Similar articles

• In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.

  Choi KH, Hong JS, Kim SK, Lee DK, Yoon SJ, Choi EC. Choi KH, et al. J Antimicrob Chemother. 1997 Apr;39(4):509-14. doi: 10.1093/jac/39.4.509. J Antimicrob Chemother. 1997. PMID: 9145824
• Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin.

  Houston AK, Jones RN. Houston AK, et al. Diagn Microbiol Infect Dis. 1994 Jan;18(1):57-9. doi: 10.1016/0732-8893(94)90134-1. Diagn Microbiol Infect Dis. 1994. PMID: 8026158
• A study of photobactericidal activity in the phenothiazinium series.

  Wainwright M, Phoenix DA, Marland J, Wareing DR, Bolton FJ. Wainwright M, et al. FEMS Immunol Med Microbiol. 1997 Sep;19(1):75-80. doi: 10.1111/j.1574-695X.1997.tb01074.x. FEMS Immunol Med Microbiol. 1997. PMID: 9322071
• A review of the antimicrobial activity of the fluoroquinolones.

  Maple P, Brumfitt W, Hamilton-Miller JM. Maple P, et al. J Chemother. 1990 Oct;2(5):280-94. doi: 10.1080/1120009x.1990.11739031. J Chemother. 1990. PMID: 2128638 Review.
• [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].

  Padeĭskaia EN, Iakovlev VP. Padeĭskaia EN, et al. Antibiot Khimioter. 1998;43(2):30-9. Antibiot Khimioter. 1998. PMID: 9551171 Review. Russian. No abstract available.